发明名称 Method for preparing (R)-praziquantel
摘要 The invention relates to a new method for preparing (R)-praziquantel. In the invention, by taking advantage of the high stereo selectivity, site selectivity and region selectivity of an enzyme, an intermediate of a pure optical and chiral (R)-praziquantel are obtained by means of the dynamic kinetic resolution of an enantiomer from the synthesized racemate or derivatives thereof, and the (R)-praziquantel is obtained by using various conventional and mature organic chemical reactions with higher yield. The method of the invention has the potential advantages of easily available raw materials, low cost, environmentally safer process and convenience for large-scale production. Also, the purity of the end product can be more than 98%. By adopting the invention, the quality of the product is improved and a basis for developing high quality of active pharmaceutical ingredients and formulations is established, and thus the pending industrial problem of purifying praziquantel over 30 years becomes solvable.
申请公布号 US9068214(B2) 申请公布日期 2015.06.30
申请号 US201414471841 申请日期 2014.08.28
申请人 Tongli Biomedical Co., Ltd 发明人 Qian Mingxin
分类号 C07D471/08;C12P41/00;C07D471/04;C07D211/60;C07B53/00;C07D217/14;C07D217/16;C07D217/26;C12P17/12;C12P17/18 主分类号 C07D471/08
代理机构 Stites & Harbison PLLC 代理人 Stites & Harbison PLLC ;Ding Cong
主权项 1. A method for preparing (R)-praziquantel, comprising the following reaction scheme: wherein R represents alkyl; and wherein the lipase stereo-selectively ammonolyzes a (R)-tetrahydroisoquinoline formate of the racemic compound 3e to obtain a pure optical (R)-tetrahydroisoquinoline formamide having the structure of compound 14.
地址 Suzhou, Jiangsu Province CN